Cargando…

S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer

S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1 monotherapy as neoadjuvant treatment. A 68-year-old man was diagnosed with gastric cancer and massive l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Jong Yul, Rha, Sun Young, Ahn, Joong Bae, Yang, Woo Ick, Noh, Sung Hoon, Chung, Hyun Cheol, Jeung, Hei-Cheul
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2008
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686958/ https://www.ncbi.nlm.nih.gov/pubmed/18363278 http://dx.doi.org/10.3904/kjim.2008.23.1.37

Ejemplares similares

Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
por: Jeung, Hei-Cheul, et al.
Publicado: (2010)

Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
por: Park, Semi, et al.
Publicado: (2009)

Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
por: Chon, Hong Jae, et al.
Publicado: (2017)

Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
por: Kim, Chan, et al.
Publicado: (2013)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
por: Kim, Han Sang, et al.
Publicado: (2012)

Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization
por: Lee, Gui Youn, et al.
Publicado: (2007)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
por: An, Ji Yeong, et al.
Publicado: (2013)

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
por: Jeung, H-C, et al.
Publicado: (2007)

Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
por: Kim, Ki-Yeol, et al.
Publicado: (2008)

Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer
por: Kim, Yong Bae, et al.
Publicado: (2013)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
por: Lee, Choong-kun, et al.
Publicado: (2022)

Novel and simple transformation algorithm for combining microarray data sets
por: Kim, Ki-Yeol, et al.
Publicado: (2007)

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
por: Lee, Byung Min, et al.
Publicado: (2021)

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
por: Lee, Jiwoo, et al.
Publicado: (2020)

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
por: Lee, Choong-kun, et al.
Publicado: (2022)

Action Tremor Associated with Lamotrigine Monotherapy
por: Yang, Ji-Hye, et al.
Publicado: (2010)

Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using (18)F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
por: Chun, You Jin, et al.
Publicado: (2019)

Detection of asymptomatic recurrence improves survival of gastric cancer patients
por: Park, Ji Soo, et al.
Publicado: (2021)

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
por: Kim, Joo Hoon, et al.
Publicado: (2010)

The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2018)

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study
por: Yoon, Kun Ho, et al.
Publicado: (2011)

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
por: Jeung, H-C, et al.
Publicado: (2006)

Prevalence and prognostic implications of psychological distress in patients with gastric cancer
por: Kim, Gun Min, et al.
Publicado: (2017)

Pathological Complete Response Following Neoadjuvant Tislelizumab Monotherapy in Treatment-Naive Locally Advanced, MMR-Deficient/MSI-High Ascending Colon Cancer: A Case Report
por: Hei, Yue, et al.
Publicado: (2022)

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy
por: Rhee, Moo-Yong, et al.
Publicado: (2015)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
por: Yeh, Jen-Hao, et al.
Publicado: (2022)

Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus
por: Hwang, You-Cheol, et al.
Publicado: (2019)

Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
por: Lim, Sun Min, et al.
Publicado: (2015)

Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells
por: Kang, Sun Kyoung, et al.
Publicado: (2020)

Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple Combination
por: Rha, Sun Young, et al.
Publicado: (2023)

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
por: Kang, Yoon-Koo, et al.
Publicado: (2021)

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
por: Hasegawa, Hirotaka, et al.
Publicado: (2022)

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Pre-treatment Nutritional Risk Assessment by NRS-2002 Predicts Prognosis in Patients With Advanced Biliary Tract Cancer: A Single Center Retrospective Study
por: Oh, Se Eung, et al.
Publicado: (2022)

Clinical Effects of Conjunctiva-Müller Muscle Resection in Anophthalmic Ptosis
por: Ha, Sung Woo, et al.
Publicado: (2007)

Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells
por: Kim, Kyung Hwan, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
por: Tong, Xie, et al.
Publicado: (2023)

Effect of Improvement in Lower Urinary Tract Symptoms on Sexual Function in Men: Tamsulosin Monotherapy vs. Combination Therapy of Tamsulosin and Solifenacin
por: Ko, Kyungtae, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cavnn6nedgj2jh2t2oo61v6hcv